581-590 of 842 results for 'consumer data right'

'Best method' a heavy burden for patentees
Insight 28 Feb 2019

Despite a global trend away from requiring patentees to disclose the best method of performing their invention, Australia continues to impose an arguably obsolete, yet increasingly onerous, statutory best method requirement. ...

Expert review into fees and costs disclosure - further changes ahead
Insight 20 Aug 2018

Many of you will be familiar with the long and tortured history of fees and costs disclosure regulation in Australia. The most recent set of issues can be traced back to 2014 when ASIC tried to address what it considered to be gaps in and inconsistent application of the former regime ...

National Electricity and Gas rules update: October 2024
Insight 13 Nov 2024

In our latest update, we examine the progress of new and existing rule change requests to the AEMC across the month of October, as well as take a closer look at how the AEMC is exploring smarter data options for consumers. ...

Honest concurrent use: a rock-solid reminder of the importance of specific evidence
Insight 28 Aug 2020

A recent decision of the Full Court of the Federal Court has highlighted that evidence of honest concurrent use of a trade mark must relate to the specific goods or services covered by an application. It's a timely reminder about the need for care in selecting the scope of the goods and services covered by a mark. ...

Breaking news
Insight 30 Apr 2020

Two important developments have unfolded over the past week. The InIP editors report ...

Global trade mark update
Insight 25 Jun 2019

There have been significant, and proposed, trade mark law developments across the globe which are likely to inform trade mark portfolio strategy. ...

Licence to infringe: Patent Office grants Sandoz licence to exploit Lexapro® patent
Insight 25 Jun 2019

In the latest chapter of one the longest-running sagas in Australian patent litigation history, the Deputy Commissioner of Patents has retrospectively granted Sandoz a licence to exploit Lundbeck's patent for its blockbuster antidepressant Lexapro® (escitalopram). The licence, only the second of its kind to be granted in Australia, provides Sandoz with a defence to Lundbeck's multi-million dollar infringement claim. ...

A change is gonna come: new .au domain name licensing rules
Insight 24 Oct 2019

au Domain Administration Ltd, (administrator and self regulatory policy body for the .au ccTLD) has released its draft licencing rules with proposed changes limiting the eligibility for non-Australian entities. ...

Parmesan by any other name: geographical indications loom large for Australian businesses
Insight 24 Oct 2019

Australian businesses may have to change the names of a range of food, drinks and agricultural products after the EU asked Australia to protect a list of hundreds of names under the proposed Australia-EU Free Trade Agreement (A-EU FTA). ...

Refine

From
To